Standardizes treatment-specific posterior outcomes over an explicit target distribution, then forms treatment contrasts within each posterior draw. This is posterior standardization, not evaluation at a single covariate profile. Treatment-specific outcomes are averaged first, and contrasts are calculated second.
Usage
marginal_effects(
object,
target,
weights = NULL,
reference = NULL,
all_contrasts = FALSE,
measure = NULL,
baseline_study = NULL,
times = NULL,
random_effect = "population",
backtransf = TRUE,
level = 0.95,
...
)Arguments
- object
A fitted
cmlnmr()object.- target
Either a data frame containing exactly the fitted effect modifiers, or a list with named
means,sds,margins, and optionalcorandn_intentries.- weights
Optional nonnegative target-row weights. This is only valid when
targetis a data frame.- reference
Reference treatment.
- all_contrasts
Return every ordered treatment contrast if
TRUE.- measure
Marginal contrast measure. Available measures depend on the outcome family.
- baseline_study
Study whose fitted intercept, and for survival whose fitted baseline hazard, is transported to the target population.
- times
Positive prediction times for survival measures, restricted to the observed follow-up support of
baseline_study. Predictions begin at model time zero rather than a landmark or delayed-entry time. For RMST these are the integration horizons. RMST measures require a piecewise-exponential donor baseline and are analytic over its intervals.- random_effect
Random-effect prediction policy. Only the population mean, which sets study-arm deviations to zero, is currently available.
- backtransf
Report ratio measures on their natural scale if
TRUE.- level
Credible interval level.
- ...
Unused.
Value
A cpaic_effects data frame. estimate, lower, and upper are on
the reporting scale. estimate_contrast, se_contrast, and
contrast_scale describe the draw-level contrast used for inference: a log
contrast for ratios and a natural-scale difference for difference measures.
Attributes record the measure, target nodes and weights, donor baseline,
random-effect policy, and sampler diagnostic status.
Measures
Available measure values are:
binomial:
"odds_ratio","risk_ratio", and"risk_difference";Gaussian:
"mean_difference";Poisson:
"rate_ratio"and"rate_difference", for unit exposure;survival:
"survival_difference","survival_ratio","risk_difference","risk_ratio","rmst_difference","rmst_ratio", and"time_specific_hazard_ratio".
A scalar marginal hazard ratio is not defined. The time-specific marginal hazard ratio generally changes with time even when the fitted conditional hazards are proportional.
Survival and risk ratios, restricted mean survival time ratios, and
time-specific marginal hazard ratios are accumulated and contrasted on the
log scale with log-sum-exp calculations before optional back-transformation.
Set backtransf = FALSE to retain the log-ratio reporting scale.
RMST measures require a piecewise-exponential donor baseline and are
evaluated analytically over its intervals. M-spline fits support marginal
survival, risk, and time-specific marginal hazard measures, but not RMST.
Target distribution
A data-frame target supplies empirical integration rows. weights are
normalized, and zero-weight rows are removed. Bernoulli modifiers must be
represented by actual 0/1 rows; a fractional prevalence is not an empirical
pseudo-patient. Continuous modifiers are accepted at their observed values,
subject to the support of the fitted margin.
A list target defines a Gaussian-copula distribution through named means,
sds, and margins. Optional cor is a latent-scale correlation matrix and
n_int is the deterministic Sobol' integration size. If cor is omitted,
the correlation retained by cmlnmr() is used. Each continuous modifier may
use a normal, gamma, lognormal, or beta margin; fitted Bernoulli
modifiers must remain Bernoulli. Independent Bernoulli modifiers are
enumerated exactly, and continuous modifiers use deterministic Sobol' nodes.
Summary nodes must reproduce requested Bernoulli strata and non-normal means
and SDs within the implementation's moment-fidelity tolerances: Bernoulli
prevalence is checked to max(1e-8, 0.1 * min(p, 1 - p)), non-normal means
to 0.1 target SD, and non-normal SDs to 15 percent relative error. A failed
gate stops with a request for a larger n_int or an empirical target. Mixed
or non-normal multivariable targets also require resolved pairwise
correlations to agree within 0.05 of a high-resolution deterministic
reference grid. The resolved nodes and weights are retained on the result.
Target-distribution uncertainty is not propagated.
Baseline transport
Binomial measures, Poisson rate differences, and every survival measure need
baseline_study. Its fitted intercept is transported to the target; survival
measures also transport its fitted baseline hazard. The target covariate
distribution is always supplied separately. This is an explicit transport
assumption, not something identified by relative treatment effects.
Gaussian mean differences and Poisson rate ratios do not need a baseline
study because the common intercept cancels.
Survival predictions start at model time zero. They are not landmark predictions and are not conditioned on delayed entry or a supplied row-level entry time. Prediction times must be positive and within the observed follow-up support retained for the selected donor study, which can be shorter than the global survival support.
Identification and random effects
Nonlinear marginal contrasts are screened at every positive-weight target
node. A passing result is labelled "first-order screen", never "exact",
because aggregate-data interactions and survival baselines can still be
weakly identified. Gaussian identity-link mean differences can be labelled
"exact" when their target-mean contrast is supported by IPD. Nonlinear
results that fail this conservative treatment-surface check are returned as
NA with basis = "first-order screen failed". This screen covers the
treatment beta/Gamma surface, not full identification of prognostic
effects, donor intercepts, or donor baseline-hazard parameters.
The target checks are support and moment checks, not a formal overlap or positivity diagnostic. No overlap statistic is estimated, and extrapolation risk remains a substantive limitation for the analyst to assess.
Only random_effect = "population" is available. It sets study-arm
deviations to zero. The function does not make predictive draws over a new
study's heterogeneity distribution and does not return marginal component
effects or marginal rankings, since nonlinear standardization does not
preserve component additivity. Nonlinear marginal effects remain
treatment-level contrasts.